Advancing Treatments for Rare Eye Diseases in Europe
Restore Vision is a project funded by the European Commission aiming to develop and test new treatments for 7 rare eye diseases (REDs). The consortium joins 10 European key players on rare eye diseases and is led by University of Galway.
About Restore Vision
+30 million
people suffer from blindness and visual impairment
About Restore Vision
Over the the next 4 years (2023-2027) the Restore Vision consortium will explore new treatments for 7 REDs by repurposing existing generic drugs, developing new theurapeutic compounds, and conducting pioneering clinical trials to ensure their safety and effectiveness.
Learn more about our work
Project in numbers
0
Years (2023-2027)
0
Partners
0
EUR in funding
0
EU Countries
0
Work packages
News
Read Restore Vision’s latest news.
07 November 2024
Restore Vision at EVER 2024
Read more about Restore Vision Special Interest Session at EVER 2024 Congress
Read more
20 October 2024
Restore Vision team participates in DOG 2024 Congress
Last October 10, the Restore Vision team participated in the Deutsche Ophthalmologische Gesellschaft – DOG 2024.
Read more
06 June 2024
Restore Vision 2nd consortium meeting
One year after the project kicked-off, our team met again in-person in Stockholm!
Read more
05 June 2024
Restore Vision partners jointly host the 7th European Anirida Conference
Restore Vision partners participated in 7th European Aniridia Conference.
Read more
12 May 2024
Antisense eye drops only or combined with fine needle diathermy could be used to regress corneal neovascularization in mice – study by UKK
At the recent ARVO meeting, Wei Zhang presented the latest findings from the University of Cologne on a new treatment to regress corneal neovascularization in mice
Read more
Interested in Restore vision?
Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.